Committed to improving women’s health and quality of life
Arstat Pharmaceuticals
Advancing
Transformational Products for Tens of Millions of Women
One of the Best Portfolios in Women’s Health
Eleven US Patents, two Phase III-ready products,
two potential blockbusters
NUVOCEPT
TM
The first and only
oral contraceptive formulated for overweight and obese women
(≈60% of 10 million US pill users)
Addressing a high public health priority in a post-Roe world
PREMRING
TM
First-in-class
medicated vaginal ring for uterine fibroids and endometriosis
(>15 million US women)
ENHANTA
TM
First-in-class
single non-hormonal therapy for painful, heavy menstrual periods
(>25 million US women)
Mission
Develop Safe and Effective Solutions for Highly Prevalent, Undertreated Reproductive Conditions and Disorders